Options
Kastrup, Andreas
Loading...
Preferred name
Kastrup, Andreas
Official Name
Kastrup, Andreas
Alternative Name
Kastrup, A.
Now showing 1 - 8 of 8
2013Journal Article Discussion [["dc.bibliographiccitation.firstpage","225"],["dc.bibliographiccitation.issue","3"],["dc.bibliographiccitation.journal","Clinical Neuroradiology"],["dc.bibliographiccitation.lastpage","229"],["dc.bibliographiccitation.volume","23"],["dc.contributor.author","Kallenberg, Kai"],["dc.contributor.author","Ruehlmann, J."],["dc.contributor.author","Baudewig, Juergen"],["dc.contributor.author","Larsen, Finn K."],["dc.contributor.author","Groeschel, S."],["dc.contributor.author","Dechent, Peter"],["dc.contributor.author","Kastrup, Andreas"],["dc.contributor.author","Knauth, Michael"],["dc.date.accessioned","2018-11-07T09:20:56Z"],["dc.date.available","2018-11-07T09:20:56Z"],["dc.date.issued","2013"],["dc.description.abstract","While acute internal carotid artery (ICA) occlusions are increasingly being treated with carotid angioplasty and stenting (CAS), the utility of CAS in subacute stages is unclear. A 65-year-old patient with an acute left ICA occlusion and pre-existing occlusion on the right side presented with dysarthria and central right-sided facial palsy. Carbon dioxide (CO2) reactivity within the left hemisphere was markedly reduced. Due to acute deterioration despite maximal conservative therapy CAS was performed 8 days after the initial event with an excellent result and symptoms subsided. CAS in subacute ICA occlusion is possible. Patients should be selected carefully. Assessment of cerebrovascular CO2 reactivity might provide valuable information."],["dc.identifier.doi","10.1007/s00062-012-0172-z"],["dc.identifier.isi","000322872800008"],["dc.identifier.pmid","22960936"],["dc.identifier.purl","https://resolver.sub.uni-goettingen.de/purl?gs-1/10274"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/28996"],["dc.notes.intern","Merged from goescholar"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Springer"],["dc.publisher.place","Heidelberg"],["dc.relation.issn","1869-1447"],["dc.relation.issn","1869-1439"],["dc.rights","Goescholar"],["dc.rights.uri","https://goescholar.uni-goettingen.de/licenses"],["dc.title","Analysis of Reserve Capacity and Subsequent Stenting in a Case of Subacute Occlusion of the Internal Carotid Artery"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dc.type.subtype","letter_note"],["dc.type.version","published_version"],["dspace.entity.type","Publication"]]Details DOI PMID PMC WOS2018Journal Article [["dc.bibliographiccitation.firstpage","431"],["dc.bibliographiccitation.issue","6"],["dc.bibliographiccitation.journal","Interventional neurology"],["dc.bibliographiccitation.lastpage","438"],["dc.bibliographiccitation.volume","7"],["dc.contributor.author","Kastrup, Andreas"],["dc.contributor.author","Brunner, Freimuth"],["dc.contributor.author","Hildebrandt, Helmut"],["dc.contributor.author","Roth, Christian"],["dc.contributor.author","Winterhalter, Michael"],["dc.contributor.author","Giessing, Carsten"],["dc.contributor.author","Papanagiotou, Panagiotis"],["dc.date.accessioned","2020-12-10T18:37:50Z"],["dc.date.available","2020-12-10T18:37:50Z"],["dc.date.issued","2018"],["dc.description.abstract","Background: In patients with large vessel occlusions, endovascular treatment (ET) has been shown to be superior to intravenous thrombolysis (IVT) in recent trials. However, it is currently unclear if patients with mild strokes also benefit from ET. Methods: We compared the discharge rates of good outcome (modified Rankin scale [mRS] ≤2), very good outcome (mRS 0–1), symptomatic intracranial hemorrhages (SICH), and infarct sizes in patients with mild strokes (admission National Institutes of Health Stroke Scale ≤10) and distal intracranial carotid artery, M1, and M2 occlusions during two time periods. Results: From 1/2008 to 10/2012 160 patients (mean age: 72 ± 12 years) were treated with IVT, and from 11/2012 to 11/2016 145 patients (mean age: 71 ± 13 years,) received ET with or without IVT. The clinical results were comparable between both treatment groups (59% after ET vs. 56% after IVT, p = 0.5 for an mRS 0–2) and (38% after ET vs. 32% after IVT, p = 0.3 for an mRS 0–1). In the subgroup of patients with an mRS ≤6, the early outcome did not differ significantly between ET and IVT either. The rates of SICH as well as the infarct sizes were not significantly different after ET compared with IVT. Conclusion: Compared with IVT, the routine use of ET did not significantly improve the early clinical or radiological outcome in patients with mild strokes and anterior circulation large vessel occlusions. Further randomized trials are urgently needed to determine the role of ET in this cohort."],["dc.identifier.doi","10.1159/000489708"],["dc.identifier.eissn","1664-5545"],["dc.identifier.issn","1664-9737"],["dc.identifier.pmid","30410521"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/77107"],["dc.language.iso","en"],["dc.notes.intern","DOI Import GROB-354"],["dc.publisher","S. Karger AG"],["dc.relation.eissn","1664-5545"],["dc.relation.issn","1664-9737"],["dc.rights","https://www.karger.com/Services/SiteLicenses"],["dc.title","Endovascular Therapy versus Thrombolysis in Patients with Mild Strokes and Large Vessel Occlusions within the Anterior Circulation"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dspace.entity.type","Publication"]]Details DOI PMID PMC2009Journal Article [["dc.bibliographiccitation.firstpage","368"],["dc.bibliographiccitation.issue","4"],["dc.bibliographiccitation.journal","Cerebrovascular Diseases"],["dc.bibliographiccitation.lastpage","374"],["dc.bibliographiccitation.volume","27"],["dc.contributor.author","Singer, Oliver C."],["dc.contributor.author","Berkefeld, Joachim"],["dc.contributor.author","Lorenz, M. W."],["dc.contributor.author","Fiehler, Jens"],["dc.contributor.author","Albers, Gregory W."],["dc.contributor.author","Lansberg, Maarten G."],["dc.contributor.author","Kastrup, Andreas"],["dc.contributor.author","Rovira, Alex"],["dc.contributor.author","Liebeskind, David S."],["dc.contributor.author","Gass, Achim"],["dc.contributor.author","Rosso, Charlotte"],["dc.contributor.author","Derex, Laurent"],["dc.contributor.author","Kim, J. S."],["dc.contributor.author","Neumann-Haefelin, T."],["dc.date.accessioned","2018-11-07T08:34:01Z"],["dc.date.available","2018-11-07T08:34:01Z"],["dc.date.issued","2009"],["dc.description.abstract","Background: In intra-arterial (IA) thrombolysis trials, higher rates of symptomatic intracerebral haemorrhage (sICH) were found than in trials with intravenous (IV) recombinant tissue plasminogen activator (tPA); this observation could have been due to the inclusion of more severely affected patients in IA thrombolysis trials. In the present study, we investigated the rate of sICH in IA and combined IV + IA thrombolysis versus IV thrombolysis after adjusting for differences in clinical and MRI parameters. Methods: In this multicenter study, we systematically analyzed data from 645 patients with anterior-circulation strokes treated with either IV or IA thrombolysis within 6 h following symptom onset. Thrombolytic regimens included (1) IV tPA treatment (n = 536) and (2) IA treatment with either tPA or urokinase (n = 74) or (3) combined IV + IA treatment with either tPA or urokinase (n = 35). Results: 44 (6.8%) patients developed sICH. sICH patients had significantly higher scores on the National Institutes of Health Stroke Scale (NIHSS) at admission and pretreatment DWI lesions. The sICH risk was 5.2% (n = 28) in IV thrombolysis, which is significantly lower than in IA (12.5%, n = 9) or IV + IA thrombolysis (20%, n = 7). In a binary logistic regression analysis including age, NIHSS score, time to thrombolysis, initial diffusion weighted imaging lesion size, mode of thrombolytic treatment and thrombolytic agent, the mode of thrombolytic treatment remained an independent predictor for sICH. The odds ratio for IA or IV + IA versus IV treatment was 3.466 (1.19-10.01, 95% CI, p < 0.05). Conclusion: In this series, IA and IV + IA thrombolysis is associated with an increased sICH risk as compared to IV thrombolysis, and this risk is independent of differences in baseline parameters such as age, initial NIHSS score or pretreatment lesion size. Copyright (C) 2009 S. Karger AG, Basel"],["dc.identifier.doi","10.1159/000202427"],["dc.identifier.isi","000264862500010"],["dc.identifier.pmid","19218803"],["dc.identifier.purl","https://resolver.sub.uni-goettingen.de/purl?gs-1/9313"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/17723"],["dc.notes.intern","Merged from goescholar"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Karger"],["dc.relation.issn","1015-9770"],["dc.rights","Goescholar"],["dc.rights.uri","https://goescholar.uni-goettingen.de/licenses"],["dc.title","Risk of Symptomatic Intracerebral Hemorrhage in Patients Treated with Intra-Arterial Thrombolysis"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dc.type.version","published_version"],["dspace.entity.type","Publication"]]Details DOI PMID PMC WOS2012Journal Article [["dc.bibliographiccitation.firstpage","2309"],["dc.bibliographiccitation.issue","11"],["dc.bibliographiccitation.journal","Journal of Neurology"],["dc.bibliographiccitation.lastpage","2318"],["dc.bibliographiccitation.volume","259"],["dc.contributor.author","Wasser, Katrin"],["dc.contributor.author","Hildebrandt, Helmut"],["dc.contributor.author","Groeschel, Sonja"],["dc.contributor.author","Stojanovic, Tomislav"],["dc.contributor.author","Schmidt, Holger"],["dc.contributor.author","Groeschel, Klaus"],["dc.contributor.author","Pilgram-Pastor, Sara M."],["dc.contributor.author","Knauth, Michael"],["dc.contributor.author","Kastrup, Andreas"],["dc.date.accessioned","2018-11-07T09:04:12Z"],["dc.date.available","2018-11-07T09:04:12Z"],["dc.date.issued","2012"],["dc.description.abstract","Although evidence is accumulating that age modifies the risk of carotid angioplasty and stenting (CAS) versus endarterectomy (CEA) for patients with significant carotid stenosis, the impact of age on cognition after either CEA or CAS remains unclear. In this study, we analyzed the effects of age on cognitive performance after either CEA or CAS using a comprehensive neuropsychological test battery with parallel test forms and a control group to exclude a learning effect. The neuropsychological outcomes after revascularization were determined in 19 CAS and 27 CEA patients with severe carotid stenosis. The patients were subdivided according to their median age (< 68 years and a parts per thousand yen68 years); 27 healthy subjects served as a control group. In all patients clinical examinations, MRI scans and a neuropsychological test battery that assessed four major cognitive domains were performed immediately before, within 72 h, and 3 months after CEA or CAS. While patients < 68 years of age showed no significant cognitive alteration after either CEA or CAS, a significant cognitive decline was observed in patients a parts per thousand yen68 years in both treatment groups (p = 0.001). Notably, this cognitive deterioration persisted in patients after CEA, whereas it was only transient in patients treated with CAS. These results demonstrate an age-dependent effect of CEA and CAS on cognitive functions. In contrast to the recently observed increased clinical complication rates in older subjects after CAS compared with CEA, CEA appears to be associated with a greater, persistent decline in cognitive performance than CAS in this subgroup of patients."],["dc.identifier.doi","10.1007/s00415-012-6491-9"],["dc.identifier.isi","000310472100006"],["dc.identifier.pmid","22527231"],["dc.identifier.purl","https://resolver.sub.uni-goettingen.de/purl?gs-1/8810"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/25062"],["dc.notes.intern","Merged from goescholar"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Springer"],["dc.publisher.place","Heidelberg"],["dc.relation.issn","0340-5354"],["dc.rights","Goescholar"],["dc.rights.uri","https://goescholar.uni-goettingen.de/licenses"],["dc.title","Age-dependent effects of carotid endarterectomy or stenting on cognitive performance"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dc.type.version","published_version"],["dspace.entity.type","Publication"]]Details DOI PMID PMC WOS2009Journal Article [["dc.bibliographiccitation.firstpage","338"],["dc.bibliographiccitation.issue","6"],["dc.bibliographiccitation.journal","European Neurology"],["dc.bibliographiccitation.lastpage","343"],["dc.bibliographiccitation.volume","62"],["dc.contributor.author","Terborg, Christoph"],["dc.contributor.author","Groeschel, Klaus"],["dc.contributor.author","Petrovitch, Alexander"],["dc.contributor.author","Ringer, Thomas"],["dc.contributor.author","Schnaudigel, Sonja"],["dc.contributor.author","Witte, Otto-Wilhelm"],["dc.contributor.author","Kastrup, Andreas"],["dc.date.accessioned","2018-11-07T08:34:27Z"],["dc.date.available","2018-11-07T08:34:27Z"],["dc.date.issued","2009"],["dc.description.abstract","Background: In acute stroke patients, there is a need for noninvasive measurement to monitor blood flow-based therapies. We investigated the utility of near-infrared spectroscopy (NIRS) to determine cerebral perfusion in these patients. Methods: Eleven patients were investigated within 1.4 +/- 2.2 days after onset of an ischemic middle cerebral artery infarction by monitoring the kinetics of an intravenous bolus of indocyanine green (ICG). For ICG kinetics, bolus peak time, time to peak (TTP = time between 0 and 100% ICG maximum), maximum ICG concentration, rise time (time between 10 and 90% ICG maximum), slope (maximum ICG/TTP), and blood flow index (BFI = maximum ICG/rise time) were obtained. Perfusion-weighted MRI (PWI) and NIRS measurements were performed within 24 h, and the interhemispherical differences of TTP values were compared. Results: Stroke patients showed an increased bolus peak time (p < 0.02), TTP (p < 0.01), and rise time (p < 0.01), whereas slope (p < 0.01) and BFI ( p ! 0.01) were diminished at the site of infarction as compared to the unaffected hemisphere. The interhemispherical differences of TTP as measured by PWI and NIRS were closely correlated (r = 0.86). Conclusions: Noninvasive measurements of cerebral ICG kinetics by NIRS provide a useful means of detecting cerebral perfusion deficits in patients with acute stroke, which correlate well with those obtained by PWI. Copyright (C) 2009 S. Karger AG, Basel"],["dc.identifier.doi","10.1159/000239794"],["dc.identifier.isi","000270366000004"],["dc.identifier.pmid","19776588"],["dc.identifier.purl","https://resolver.sub.uni-goettingen.de/purl?gs-1/9319"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/17815"],["dc.notes.intern","Merged from goescholar"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Karger"],["dc.relation.issn","0014-3022"],["dc.rights","Goescholar"],["dc.rights.uri","https://goescholar.uni-goettingen.de/licenses"],["dc.title","Noninvasive Assessment of Cerebral Perfusion and Oxygenation in Acute Ischemic Stroke by Near-Infrared Spectroscopy"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dc.type.version","published_version"],["dspace.entity.type","Publication"]]Details DOI PMID PMC WOS2011Journal Article [["dc.bibliographiccitation.artnumber","77"],["dc.bibliographiccitation.journal","BMC Neurology"],["dc.bibliographiccitation.volume","11"],["dc.contributor.author","Schmidt, Holger"],["dc.contributor.author","Heinemann, Trutz"],["dc.contributor.author","Elster, Judith"],["dc.contributor.author","Djukic, Marija"],["dc.contributor.author","Harscher, Stefan"],["dc.contributor.author","Neubieser, Katja"],["dc.contributor.author","Prange, Hilmar"],["dc.contributor.author","Kastrup, Andreas"],["dc.contributor.author","Rohde, Veit"],["dc.date.accessioned","2018-11-07T08:54:58Z"],["dc.date.available","2018-11-07T08:54:58Z"],["dc.date.issued","2011"],["dc.description.abstract","Background: Decompressive hemicraniectomy is a life-saving procedure for patients with malignant middle cerebral artery infarctions. However, the neuropsychological sequelae in such patients have up to now received little attention. In this study we not only describe neuropsychological deficits but also the quality of life and the extent of depression and other psychiatric symptoms in patients after complete media infarction of the non-speech dominant hemisphere. Methods: 20 patients from two different university hospitals (mean +/- standard deviation: 52 +/- 14 years of age) who had undergone hemicraniectomy with duraplasty above the non-speech dominant hemisphere at least one year previously were examined using a thorough neurological and neuropsychological work-up. The quality of life and the extent of psychiatric problems were determined on the basis of self-estimation questionnaires. The patients were asked whether they would again opt for the surgical treatment when considering their own outcome. 20 healthy persons matched for age, gender and education served as a control group. Results: All patients but one were neurologically handicapped, half of them severely. Age was significantly correlated with poorer values on the Rankin scale and Barthel index. All cognitive domain z values were significantly lower than in the control group. Upon re-examination, 18 of 20 patients were found to be cognitively impaired to a degree that fulfilled the formal DSM IV criteria for dementia. Conclusions: Patients with non-speech dominant hemispheric infarctions and decompressive hemicraniectomy are at high risk of depression and severe cognitive impairment."],["dc.identifier.doi","10.1186/1471-2377-11-77"],["dc.identifier.isi","000293016900002"],["dc.identifier.pmid","21699727"],["dc.identifier.purl","https://resolver.sub.uni-goettingen.de/purl?gs-1/6834"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/22796"],["dc.notes.intern","Merged from goescholar"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Biomed Central Ltd"],["dc.relation.issn","1471-2377"],["dc.rights","CC BY 2.0"],["dc.rights.uri","https://creativecommons.org/licenses/by/2.0"],["dc.title","Cognition after malignant media infarction and decompressive hemicraniectomy - a retrospective observational study"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dc.type.version","published_version"],["dspace.entity.type","Publication"]]Details DOI PMID PMC WOS2011Journal Article [["dc.bibliographiccitation.firstpage","1228"],["dc.bibliographiccitation.issue","7"],["dc.bibliographiccitation.journal","Journal of Neurology"],["dc.bibliographiccitation.lastpage","1233"],["dc.bibliographiccitation.volume","258"],["dc.contributor.author","Groeschel, Klaus"],["dc.contributor.author","Schnaudigel, Sonja"],["dc.contributor.author","Wasser, Katrin"],["dc.contributor.author","Pilgram-Pastor, Sara M."],["dc.contributor.author","Ernemann, Ulrike"],["dc.contributor.author","Knauth, Michael"],["dc.contributor.author","Kastrup, Andreas"],["dc.date.accessioned","2018-11-07T08:54:42Z"],["dc.date.available","2018-11-07T08:54:42Z"],["dc.date.issued","2011"],["dc.description.abstract","Treatment of a symptomatic stenosis is known to be most beneficial within 14 days after the presenting event but this can frequently not be achieved in daily practice. The aim of this study was the assessment of factors responsible for this time delay to treatment. A retrospective analysis of a prospective two-center CAS database was carried out to investigate the potential factors that influence a delayed CAS treatment. Of 374 patients with a symptomatic carotid stenosis, 59.1% were treated beyond a parts per thousand yen14 days. A retinal TIA event (OR = 3.59, 95% CI 1.47-8.74, p < 0.01) was found to be a predictor for a delayed treatment, whereas the year of the intervention (OR = 0.32, 95% CI 0.20-0.50, p < 0.01) and a contralateral carotid occlusion (OR = 0.42, 95% CI 0.21-0.86, p = 0.02) were predictive of an early treatment. Similarly, within the subgroup of patients with transient symptoms, the year of the intervention (OR = 0.28, 95% CI 0.14-0.59, p < 0.01) was associated with an early treatment, whereas a retinal TIA as the qualifying event (OR = 6.96, 95% CI 2.37-20.47, p < 0.01) was associated with a delayed treatment. Treatment delay was most pronounced in patients with an amaurosis fugax, whereas a contralateral carotid occlusion led to an early intervention. Although CAS is increasingly performed faster in the last years, there is still scope for an even more accelerated treatment strategy, which might prevent future recurrent strokes prior to treatment."],["dc.identifier.doi","10.1007/s00415-011-5909-0"],["dc.identifier.isi","000292554700004"],["dc.identifier.pmid","21264472"],["dc.identifier.purl","https://resolver.sub.uni-goettingen.de/purl?gs-1/8055"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/22731"],["dc.notes.intern","Merged from goescholar"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Springer"],["dc.publisher.place","Heidelberg"],["dc.relation.issn","0340-5354"],["dc.rights","Goescholar"],["dc.rights.uri","https://goescholar.uni-goettingen.de/licenses"],["dc.title","Factors associated with time delay to carotid stenting in patients with a symptomatic carotid artery stenosis"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dc.type.version","published_version"],["dspace.entity.type","Publication"]]Details DOI PMID PMC WOS2016Journal Article [["dc.bibliographiccitation.artnumber","154"],["dc.bibliographiccitation.journal","Frontiers in Neurology"],["dc.bibliographiccitation.volume","7"],["dc.contributor.author","Hanken, Katrin"],["dc.contributor.author","Bosse, Mona"],["dc.contributor.author","Moehrke, Kim"],["dc.contributor.author","Eling, Paul"],["dc.contributor.author","Kastrup, Andreas"],["dc.contributor.author","Antal, Andrea"],["dc.contributor.author","Hildebrandt, Helmut"],["dc.date.accessioned","2018-11-07T10:08:26Z"],["dc.date.available","2018-11-07T10:08:26Z"],["dc.date.issued","2016"],["dc.description.abstract","Background: Fatigue in multiple sclerosis (MS) patients appears to correlate with vigilance decrement as reflected in an increase in reaction time (RT) and errors with prolonged time-on-task. Objectives: The aim of this study was to investigate whether anodal transcranial direct current stimulation (tDCS) over the right parietal or frontal cortex counteracts fatigue-associated vigilance decrement and subjective fatigue. Methods: In study I, a randomized double-blind placebo-controlled study, anodal tDCS (1.5 mA) was delivered to the right parietal cortex or the right frontal cortex of 52 healthy participants during the first 20 min of a 40-min lasting visual vigilance task. Study II, also a randomized double-blind placebo-controlled study, investigated the effect of anodal tDCS (1.5 mA) over the right parietal cortex in 46 MS patients experiencing cognitive fatigue. tDCS was delivered for 20 min before patients performed a 20-min lasting visual vigilance task. Results: Study I showed that right parietal stimulation, but not right frontal stimulation, counteracts the increase in RT associated with vigilance decrement. Hence, only right parietal stimulation was applied to the MS patients in study II. Stimulation had a significant effect on vigilance decrement in mildly to moderately cognitively fatigued MS patients. Vigilance testing significantly increased the feeling of fatigue independent of stimulation. Conclusion: Anodal tDCS over the right parietal cortex can counteract the increase in RTs during vigilance performance, but not the increase in subjective fatigue. This finding is compatible with our model of fatigue in MS, suggesting a dissociation between the feeling and the behavioral characteristics of fatigue."],["dc.description.sponsorship","Novartis"],["dc.identifier.doi","10.3389/fneur.2016.00154"],["dc.identifier.isi","000383751400001"],["dc.identifier.pmid","27708612"],["dc.identifier.purl","https://resolver.sub.uni-goettingen.de/purl?gs-1/13780"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/39462"],["dc.notes.intern","Merged from goescholar"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Frontiers Media Sa"],["dc.relation.issn","1664-2295"],["dc.rights","CC BY 4.0"],["dc.rights.uri","https://creativecommons.org/licenses/by/4.0"],["dc.title","Counteracting Fatigue in Multiple Sclerosis with Right Parietal Anodal Transcranial Direct Current Stimulation"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dc.type.version","published_version"],["dspace.entity.type","Publication"]]Details DOI PMID PMC WOS